Skip to main content<br>Search peptides, vendors, or CAS number⌘K

Search peptides, vendors, or CAS number⌘K

BlogAndrew Huberman's Peptide Recommendations 2026<br>What the Stanford neuroscientist actually uses, recommends, and warns about<br>Peptide Portal ResearchEditorial Team

·May 18, 2026·14 min read<br>TLDR: Andrew Huberman, the Stanford neuroscientist behind the Huberman Lab podcast, has discussed over a dozen peptides across his episodes, but he's only personally used a handful. His top picks based on personal experience include BPC-157 (which resolved his chronic back pain in just two injections), Pinealon (which doubled his REM sleep), and Semax (for cognitive focus). For growth hormone support, he favors Ipamorelin at 100 mcg as the "cleanest" option. Huberman strongly advises getting peptides through board-certified physicians and compounding pharmacies rather than gray market sources, and he stresses the cancer risks of peptides that upregulate VEGF or growth hormone pathways.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before using any peptides. Many peptides discussed here are not FDA-approved for the uses described and are classified as research compounds.

Why Does Andrew Huberman Talk About Peptides?

Huberman's interest in peptides stems from his background in neurobiology and his willingness to self-experiment. Unlike many academics who stay theoretical, Huberman openly shares what he's tried, what worked, and what didn't.

His main peptide episode, "Benefits & Risks of Peptide Therapeutics for Physical & Mental Health," aired in April 2024 and remains the most detailed breakdown of peptide science from a mainstream science communicator. He followed this with a deep-dive featuring peptide physician Dr. Craig Koniver in October 2024, which covered clinical protocols and stacking strategies.

Huberman's approach stands out because he emphasizes both the potential benefits and the legitimate risks. He's not selling anything, and he's repeatedly warned listeners about the dangers of gray market sourcing and the real possibility of tumor promotion from certain compounds.

Which Peptides Has Huberman Actually Taken?

Based on his public statements across podcast episodes and interviews, Huberman has personally experimented with five peptides:

BPC-157 (Body Protection Compound-157)

This is Huberman's most dramatic personal success story. He developed L5 disc compression from deadlifting that caused persistent lower back pain. After trying massage, heat therapy, and electrical stimulation without relief, he used BPC-157.

"Within two injections of BPC-157, my persistent back pain was completely resolved," Huberman stated on his April 2024 episode.

His protocol: 300-500 micrograms subcutaneously, injected near the injury site, two to three times weekly for about eight weeks, followed by an eight to ten week break.

The catch: BPC-157 was placed on the FDA's Category 2 restricted list in October 2023. As of May 2026, it remains technically banned for compounding, though HHS Secretary RFK Jr. announced in February 2026 that approximately 14 restricted peptides are expected to return to Category 1 status.

Current alternative: Pentadeca Arginate (PDA) shares the same 15-amino-acid sequence with an arginine salt instead of acetate. Dr. Craig Koniver reports results "very close to BPC" at 250-500 mcg daily.

Pinealon (REM Sleep Enhancement)

This is the peptide Huberman found most surprising. Over four to six months of intermittent use, Pinealon doubled his REM sleep from roughly 1-1.5 hours to nearly 3 hours per night, tracked objectively with sleep monitoring devices.

"I've tried a lot of peptides. I rarely keep doing them for long," Huberman noted. "Pinealon has very little human data, but I got great results from it."

His protocol: Injectable Pinealon combined with oral glycine (3,000-5,000 mg), used intermittently rather than nightly.

Pinealon is one of the smallest peptides available and is believed to regenerate pinealocytes, the cells in the pineal gland that produce melatonin.

Sermorelin (Growth Hormone Secretagogue)

Huberman used Sermorelin for one to two nights weekly over a period of a couple years. The results were mixed.

"Sermorelin gave me great sleep, but only in the first part of the night," he explained. "It nuked my rapid eye movement sleep in the second half of the night and spiked my prostate-specific antigen."

He has since stopped taking Sermorelin almost completely due to these side effects. This honest assessment of a negative experience is typical of Huberman's transparent approach.

MK-677 (Oral Growth Hormone Secretagogue)

Huberman tried MK-677 only once and described the experience negatively. The oral peptide "destroyed sleep through extreme hunger," making it impractical for regular use in his view. MK-677 was subsequently removed from the FDA's compounding approval...